Symbol Lookup

Friday January 20, 2017 11:05 AM ET. Data delayed 15 minutes.
6.90
-0.01 (-0.11%)
Bid/Lots
6.88/2
Ask/Lots
6.90/3
Open/Prev Close
6.90/6.91
Day Range
6.86-6.98
52-Week Range
5.76-13.68
Vol/Avg Daily Vol
5.3K/96.3K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
European ADRs Edge Higher as Pharma Stocks, Manufacturers See Mixed Fortunes
11:17AM ET on Friday Jan 13, 2017 by MT Newswires
11:17 AM EST, 01/13/2017 (MT Newswires) -- American depository receipts of European stocks were 0.3% higher at 123.10 on the Bank of New York Mellon Europe ADR Index on Friday morning. Gainers in Continental Europe were led by Forward Pharma (FWP...
The Top 200 IVD Companies Worldwide
3:57PM ET on Wednesday Jan 11, 2017 by PR Newswire

Did you know?

Abbott Diagnostics is #1 in immunoassay and blood screening worldwide.- EKF Diagnostics sold over 18,000 point-of-care analysers in 2014.- Transasia Bio-Medicals is India's largest in-vitro diagnostic company.- Marcel van K...

Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages Investors to Contact the Firm
5:30PM ET on Thursday Jan 05, 2017 by Business Wire

Bragar Eagel & Squire, P.C. is investigating potential claims against Trinity Biotech plc (NASDAQ:TRIB) concerning possible violations of the federal securities laws.

On October 4, 2016, Trinity revealed that it was wit...

European ADRs Fractionally Higher as Pharma Stocks Rally
10:33AM ET on Wednesday Dec 21, 2016 by MT Newswires
10:33 AM EST, 12/21/2016 (MT Newswires) -- American depository receipts of European stocks were 0.2% higher at 119.83 on the Bank of New York Mellon Europe ADR Index on Wednesday morning. Pharmaceutical companies led the gainers in Continental Eu...

Company Information

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

CONTACT INFORMATION

HeadquartersIDA Business Park
BRAY, Ireland 18
Phone--
Fax--

EXECUTIVE OFFICERS

Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, and Vice President CardiacEric Brouwer
Executive DirectorJames Walsh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$165.6MBeta1.18
Revenue (TTM)$100.9MEPS$0.07
Shares Out.24.0MBook Value$8.93
Dividend Yield0.00%P/E93.9x
Annual Dividend Rate0.00 USDPrice/Sales (TTM)1.6
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin9.94%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample